| Literature DB >> 25745516 |
Sayed Shahabuddin Hoseini1, Martin G Sauer2.
Abstract
BACKGROUND: Over the last decades, molecular cloning has transformed biological sciences. Having profoundly impacted various areas such as basic science, clinical, pharmaceutical, and environmental fields, the use of recombinant DNA has successfully started to enter the field of cellular engineering. Here, the polymerase chain reaction (PCR) represents one of the most essential tools. Due to the emergence of novel and efficient PCR reagents, cloning kits, and software, there is a need for a concise and comprehensive protocol that explains all steps of PCR cloning starting from the primer design, performing PCR, sequencing PCR products, analysis of the sequencing data, and finally the assessment of gene expression. It is the aim of this methodology paper to provide a comprehensive protocol with a viable example for applying PCR in gene cloning.Entities:
Keywords: Biological engineering; Cloning; Educational guide; Polymerase chain reaction (PCR); Recombinant DNA; Transduction; Transfection
Year: 2015 PMID: 25745516 PMCID: PMC4350901 DOI: 10.1186/1754-1611-9-2
Source DB: PubMed Journal: J Biol Eng ISSN: 1754-1611 Impact factor: 4.355
Figure 1Overview of the start and the end of the gene of interest. (A) The nucleotide sequences at the start and the end of the tdTomato gene are shown. The coding strand nucleotides are specified in bold (B) The nucleotide sequences of the forward and reverse primers containing proper restriction enzyme sites and the Kozak sequence are shown.
Figure 2Choosing proper restriction enzymes based on defined criteria for PCR cloning. (A) Two single-cutter restriction enzymes (E1 and E2) are located downstream of the promoter. (B) E1 and E2 restriction enzymes cut the plasmid downstream of the promoter several (here two times for each enzyme) times. (C) The E1 restriction enzyme cuts the plasmid downstream of the promoter more than once. (D) The PCR product, which contains the tdTomato gene and the restriction enzyme sites, was run on a gel before being extracted for downstream applications.
Common host strains in gene cloning
| Application |
|
|---|---|
| Transformation of large plasmids | GeneHogs, XL10 Gold, STBL4, SURE |
| Generation of single-stranded (ssDNA) | INV110, JM109, JS5, NM522, SCS110, SURE, STBL4, XL10 Gold, XL1 Blue, TG1 |
| For storage of plasmids that tend to recombine | DH10B, DH5α, STBL2, STBL3, STBL4, SURE, GeneHogs, Hb101, JM109, JS5, XL10 Gold, XL1 Blue, GC5, GC10 |
| Rapid cloning (fast cell growth) | Mach1 |
| Cloning of unstable plasmids | SURE, STBL2, STBL3, STBL4 |
| High efficiency cloning for library construction | XL10-Gold, MegaX, DH10B |
| Blue/white screening | DH10B, DH5α, MC1061, TOP10, XL1 Blue, Hb101, NM522, SCS110, STBL4, SURE, XL10 Gold, GeneHogs, INV110, JM109, JS5, GC5, GC10 |
| For site-directed mutagenesis | XL- |
| For random mutagenesis | XL1-Red |
| For expression of toxic genes | ABLE C, ABLE K |
| General cloning and storage of plasmids | DH10B, DH5α, MC1061, TOP10, XL1-Blue, Hb101 |
| For proliferation of plasmids encoding the ccdB toxic gene (important in Gateway cloning) | ccdB survival, DB3.1, XL1 Blue, JM109, DH5α |
| For generation of unmethylated DNA to be cut with methylation-sensitive restriction enzymes | JM110, ER2925, INV110, DM1, SCS110, E4109S |
Data are derived from enzyme providers’ data sheets, the following website, and this reference [14]. http://openwetware.org/wiki/E._coli_genotypes.
Figure 3Designing primers based on defined criteria for PCR cloning. (A-B) Sequences of the forward and the reverse primer are depicted. The end of the coding strand is to be converted into the reverse complement format for the reverse primer design. For more information, please see the text.
Common vectors in gene cloning
| Plasmid name | Advantages | Disadvantages | References |
|---|---|---|---|
| pBR322 | Small size (4.4 kb), variety of cloning sites, medium copy number (15–20) | [ | |
| pUC18 and pUC19 | Small size (2.7 kb), high copy number (500–700), multiple cloning site, sequencing using M13 primers | Not good if target protein is toxic or for membrane proteins, needs blue/white screen | [ |
| pLG338 | General purpose plasmid vector, size 7.3 kb, low copy number (6–8), genes coding for membrane and regulatory proteins which cannot be cloned into high-copy-number plasmids | [ | |
| pMiniT | Inserted PCR product disrupts a toxic minigene, no blue/white selection required, works for both blunt end and single-base overhang-containing PCR products | NEB | |
| pCR™4Blunt-TOPO® | Inserted PCR product disrupts | Needs blunt-end PCR products | Life Technologies |
| pDrive | Size 3.8 kb | Needs single A overhangs, not usable for proofreading DNA polymerases, needs blue/white screening | QIAGEN |
| StrataClone Blunt PCR Cloning Vector pSC-B-amp/kan | Uses the DNA topoisomerase I and the DNA recombination activity of Cre recombinase, up to 9 kb PCR product size | Needs blunt-end PCR products, needs special competent cells for transformation (cells expressing Cre recombinase) | Agilent Technologies |
| pJET1.2/blunt | Inserted PCR product disrupts the toxic gene | Thermo Scientific |
Data are derived from vector providers or the cited references. pBR322, pUC18, pUC19, and pLG338 are cloning vectors and the rest are PCR sequencing vectors.
Figure 4Sequence analysis of the PCR product using the NCBI BLAST platform. (A) On the NCBI BLAST webpage, the “nucleotide blast” option is chosen (marked by the oval line). (B) The “blastn” option appears by default (marked by the circle). The sequence of the gene of interest (flanked by the restriction sites as previously designed for the PCR primers) and the PCR product are to be inserted to the “Enter Query Sequence” and “Enter Subject Sequence” boxes. Sequences can also be uploaded as FASTA files. (C) Nucleotide alignment of the first 60 nucleotides is shown. Two important items for sequence analysis are marked by oval lines.
Figure 5Vector and insert plasmid maps A) Illustration of the CloneJET plasmid containing the PCR product. Insertion of the PCR product in the cloning site of the plasmid disrupts the integrity of the toxic gene eco47IR and allows the growth of transgene positive clones. The plasmid was cut with the AgeI and SalI enzymes generating two fragments of 3 kb and 0.7 kb in size. The 0.7 kb fragment (tdTomato gene) was used as the insert for cloning. (B) Illustration of the vector plasmid. The plasmid was cut with the AgeI and SalI enzymes generating two fragments of 4.9 kb and 0.7 kb in size. The 4.9 kb fragment was used as the vector for cloning. AMP: Ampicillin resistance gene; PRE: posttranscriptional regulatory element; MPSV: myeloproliferative sarcoma virus promoter.
Figure 6Screening of the final plasmid with restriction enzymes. Illustration of the final plasmid is shown. For screening, the plasmid was cut with the BsiwI enzyme generating two fragments of 4.8 kb and 0.8 kb in size. AMP: Ampicillin resistance gene; PRE: posttranscriptional regulatory element; MPSV: myeloproliferative sarcoma virus promoter.
Figure 7Assessing expression of the cloned gene. (A, B) HEK293T cells were transfected with Gag/Pol, VSVG, and tdTomato plasmids. The expression of the tdTomato gene was assessed using a fluorescence microscope. Fluorescent images were superimposed on a bright-field image for the differentiation of positively transduced cells. Transfection efficiency was determined based on the expression of tdTomato after 24 hours. Non-transfected HEK293T cells were used as controls (blue histogram). (C, D) The murine leukemia cell line C1498 was transduced with fresh virus. Four days later, transgene expression was assessed by fluorescence microscopy (C) and flow cytometry (D). Non-transduced C1498 cells were used as controls (blue histogram). Scale bars represent 30 μm.